JP Morgan slashes price target on Clover Health Investments Corp. [CLOV] – find out why.

Clover Health Investments Corp. [NASDAQ: CLOV] slipped around -0.15 points on Friday, while shares priced at $8.07 at the close of the session, down -1.82%. The company report on July 23, 2021 that Clover Health Joins NCQA for New Quality Innovation Series.

Clover Health (Nasdaq: CLOV) (“Clover”), an innovative technology company committed to improving health equity for America’s underserved seniors, announced its sponsorship of the 2021 Quality Innovation Series.

The National Committee for Quality Assurance (NCQA) is bringing together leaders in healthcare to present the Quality Innovation Series once again. This virtual series will gather leaders who develop measures, write standards and help shape healthcare quality, in an effort to help move healthcare quality and equity forward through seminars, talks and panels. Sessions will include NCQA leadership, health plans, providers and others sharing best practices in healthcare. The Quality Innovation Series kicked off on June 17th and will continue with weekly live sessions through November 18th.

Clover Health Investments Corp. stock is now -51.88% down from its year-to-date (YTD) trading value. CLOV Stock saw the intraday high of $8.32 and lowest of $8.03 per share. The company’s 52-week high price is 28.85, which means current price is +27.89% above from all time high which was touched on 06/09/21.

Compared to the average trading volume of 53.57M shares, CLOV reached a trading volume of 7322236 in the most recent trading day, which is why market watchdogs consider the stock to be active.

What do top market gurus say about Clover Health Investments Corp. [CLOV]?

Based on careful and fact-backed analyses by Wall Street experts, the current consensus on the target price for CLOV shares is $9.50 per share. Analysis on target price and performance of stocks is usually carefully studied by market experts, and the current Wall Street consensus on CLOV stock is a recommendation set at 3.30. This rating represents a strong Buy recommendation, on the scale from 1 to 5, where 5 would mean strong sell, 4 represents Sell, 3 is Hold, and 2 indicates Buy.

JP Morgan have made an estimate for Clover Health Investments Corp. shares, keeping their opinion on the stock as Underweight, with their previous recommendation back on July 12, 2021. The new note on the price target was released on June 10, 2021, representing the official price target for Clover Health Investments Corp. stock. Previously, the target price had yet another drop from $15 to $9, while BofA Securities kept a Neutral rating on CLOV stock.

The Average True Range (ATR) for Clover Health Investments Corp. is set at 0.81, with the Price to Sales ratio for CLOV stock in the period of the last 12 months amounting to 16.75. The Price to Book ratio for the last quarter was 5.17, with the Price to Cash per share for the same quarter was set at 1.65.

How has CLOV stock performed recently?

Clover Health Investments Corp. [CLOV] gain into the green zone at the end of the last week, gaining into a positive trend and gaining by 0.25. With this latest performance, CLOV shares dropped by -39.41% in over the last four-week period, additionally sinking by -42.15% over the last 6 months – not to mention a drop of -24.23% in the past year of trading.

Overbought and oversold stocks can be easily traced with the Relative Strength Index (RSI), where an RSI result of over 70 would be overbought, and any rate below 30 would indicate oversold conditions. An RSI rate of 50 would represent a neutral market momentum. The current RSI for CLOV stock in for the last two-week period is set at 38.66, with the RSI for the last a single of trading hit 34.84, and the three-weeks RSI is set at 42.07 for Clover Health Investments Corp. [CLOV]. The present Moving Average for the last 50 days of trading for this stock 10.49, while it was recorded at 8.17 for the last single week of trading, and 10.53 for the last 200 days.

Clover Health Investments Corp. [CLOV]: Deeper insight into the fundamentals

Operating Margin for any stock indicates how profitable investing would be, and Clover Health Investments Corp. [CLOV] shares currently have an operating margin of -5752.28. Clover Health Investments Corp.’s Net Margin is presently recorded at -5752.28.

Return on Total Capital for CLOV is now -1.70, given the latest momentum, and Return on Invested Capital for the company is -1.70. Return on Equity for this stock declined to -1.70, with Return on Assets sitting at -1.57. When it comes to the capital structure of this company, Clover Health Investments Corp. [CLOV] has a Total Debt to Total Equity ratio set at 0.10. Additionally, CLOV Total Debt to Total Capital is recorded at 0.10, with Total Debt to Total Assets ending up at 0.09.

Reflecting on the efficiency of the workforce at the company, Clover Health Investments Corp. [CLOV] managed to generate an average of -$14,727 per employee.Clover Health Investments Corp.’s liquidity data is similarly interesting compelling, with a Quick Ratio of 4.70 and a Current Ratio set at 4.70.

Earnings analysis for Clover Health Investments Corp. [CLOV]

The progress of the company may be observed through the prism of EPS growth rate, while Wall Street analysts are focusing on predicting the 5-year EPS growth rate for CLOV. When it comes to the mentioned value, analysts are expecting to see the 5-year EPS growth rate for Clover Health Investments Corp. go to 32.00%.

Insider trade positions for Clover Health Investments Corp. [CLOV]

There are presently around $1,259 million, or 95.00% of CLOV stock, in the hands of institutional investors. The top three institutional holders of CLOV stocks are: GREENOAKS CAPITAL PARTNERS LLC with ownership of 96,331,338, which is approximately New of the company’s market cap and around 0.30% of the total institutional ownership; VANGUARD GROUP INC, holding 26,185,529 shares of the stock with an approximate value of $211.32 million in CLOV stocks shares; and BAILLIE GIFFORD & CO, currently with $41.5 million in CLOV stock with ownership of nearly New of the company’s market capitalization.

>> 7 Top Picks for the Post-Pandemic Economy <<

Positions in Clover Health Investments Corp. stocks held by institutional investors increased at the end of August and at the time of the August reporting period, where 100 institutional holders increased their position in Clover Health Investments Corp. [NASDAQ:CLOV] by around 150,681,754 shares. Additionally, 71 investors decreased positions by around 11,825,116 shares, while 14 investors held positions by with 6,552,760 shares. The mentioned changes placed institutional holdings at 155,954,110 shares, according to the latest SEC report filing. CLOV stock had 83 new institutional investments in for a total of 148,683,927 shares, while 52 institutional investors sold positions of 8,848,910 shares during the same period.

Share on facebook
Facebook
Share on twitter
Twitter
Share on linkedin
LinkedIn
Share on skype
Skype
Share on reddit
Reddit

Leave a Comment

Your email address will not be published. Required fields are marked *

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam

SPECIAL GIFT

WE HAVE A GIFT FOR YOU

Download Free eBook For

7 GROWTH STOCKS FOR 2021

100% free. stop anytime no spam